Abstract:Background: The dysfunction of vascular endothelial cells plays a key role in starting arterial restenosis. The circulating endothelial progenitor cells (EPCs) can be mobilised by cytokines and are recruited to sites of injury, where they may participate in intima repair and the recovery of endothelial function. In the present study, we examined the hypothesis that mobilisation of EPCs by exogenous recombinant human granulocyte-colony stimulating factor (rhG-CSF) can promote vascular proliferation, reduce vascular inflammation and decrease the rate of restenosis.Methods: Male rats were randomly divided into the rhG-CSF and control groups. The animals were injected daily with 30 g/kg rhG-CSF or 0.9% NaCl subcutaneously for 7 days, then the animals underwent balloon angioplasty of the common carotid artery. The animals were euthanased at 2 or 4 weeks after injury, and the carotid arteries were harvested and processed for immunohistochemistry, scanning electron microscopy (SEM), morphometric analysis of endothelialisation and neointimal formation at 1 hour, and 3, 7, 14 and 28 days after injury. Immunohistochemistry for proliferation cell nuclear antigen (PCNA) and reverse transcriptase polymerase chain reaction (RT-PCR) for endothelial nitric oxide synthase (eNOS) mRNA were also conducted for evaluating the proliferation of cells of the vessel wall and the possible mechanism of the repairing.Results: Four weeks after balloon damage, SEM showed increased re-endothelialisation of the denuded vessels in the G-CSF treated animals compared with the control animals [(60.6 +/- 7.3)% versus (41.6 +/- 3.3)%, p < 0.01]. Re-endothelialisation was paralleled by a decrease in inflammation in the vessel wall. Histological examination showed that neointimal formation, vascular smooth muscle cells and fibrous tissue of the G-CSF group were less than those of the control group. Morphometry showed the lumen area of the G-CSF group was larger than that of the control group, and the neointimal area and percent of intimal hyperplasia were significantly smaller than those of the control group. Immunohistochemical staining for PCNA positive cells was less in the G-CSF treated animals compared with the control animals (42.9% versus 72.8%, p < 0.01).Conclusion: rhG-CSF-induced mobilisation of EPCs regenerated endothelium and inhibited neointimal hyperplasia after vascular injury. This cytokine therapy may be a feasible strategy for the promotion of re-endothelialisation after angioplasty.

Beneficial Effects Of Granulocyte-Colony Stimulating Factor On Small-Diameter Heparin Immobilized Decellularized Vascular Graft

Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor.

Effects of Granulocyte-Colony Stimulating Factor on the Repair of Balloon-Injured Arteries.

The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration.

Granulocyte Colony Stimulating Factor for Prevention of Restenosis by Accelerating Endothelial Progenitor Cells Repair

[Constructing a Small-Diameter Decellularized Vascular Graft Pre-Loaded with Bfgf].

Promotion of angiogenesis by sustained release of rhGM-CSF from heparinized collagen/chitosan scaffolds.

The effect of heparinized decellularized scaffolds on angiogenic capability.

Granulocyte Colony-Stimulating Factor Mobilize Marrow and Promote the Injured Endothelium Repair

Granulocyte-colony Stimulating Factor Mediates Neovascularization in Acellular Dermal Matrix-Transplanted Areas by Promoting Endothelial Progenitor Cell Homing

Localized COUP‐TFII pDNA Delivery Modulates Stem/Progenitor Cell Differentiation to Enhance Endothelialization and Inhibit Calcification of Decellularized Allografts

Nanofibrous Vascular Scaffold Prepared from Miscible Polymer Blend with Heparin/stromal Cell-Derived Factor-1 Alpha for Enhancing Anticoagulation and Endothelialization

Improved Endothelialization of Vascular Grafts by Local Release of Growth Factor from Heparinized Collagen Matrices

Constructing small-caliber anticoagulant vascular grafts using decellularized scaffolds with heparin immobilization

Engineered Vascular Graft Using Nanoscale Decellularized Arteries Modified with Controlled-Release Heparin and Vascular Endothelial Growth Factor

Hybrid Small-Diameter Vascular Grafts: Anti-expansion Effect of Electrospun Poly Ε-Caprolactone on Heparin-Coated Decellularized Matrices

Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor.

Characterization of a Heparinized Decellularized Scaffold and Its Effects on Mechanical and Structural Properties

Development of decellularized aortic valvular conduit coated by heparin-SDF-1α multilayer.

Enhancing small diameter tissue engineered vascular grafts with heparin and hepatocyte growth factor: A promising approach

Using GRGDSPC peptides to improve re-endothelialization of decellularized pancreatic scaffolds